The HELIOS Study and the Multi-Omic Future of Asian Health Research

Beyond the Single-Layer Genome

Most genomic studies examine one biological layer at a time. The Health for Life in Singapore (HELIOS) study takes a fundamentally different approach. By integrating whole-genome sequencing, RNA sequencing, DNA methylation quantification, and metabolomic profiling with detailed lifestyle and physiological measurements, HELIOS constructs a multi-dimensional portrait of Asian health.

The study, based at Nanyang Technological University and operating under the PRECISE-SG100K umbrella, has enrolled 10,004 Asian men and women of Chinese, Malay, and Indian descent.

What the Data Reveals

HELIOS researchers have documented extensive lifestyle, physiological, genomic, and molecular diversity between Singapore’s distinct Asian ethnic groups. Perhaps more strikingly, the data show biological interconnectivity between functional layers—how genome regulation patterns correlate with factors like educational attainment and metabolic health.

These findings challenge assumptions that Asian populations can be treated as a homogeneous group in clinical research. They also underscore why precision health must account for intra-population diversity, not just continental ancestry categories.

A Platform for Discovery

The HELIOS cohort serves as a state-of-the-art platform for biomedical researchers seeking to understand the aetiology and pathogenesis of diverse disease outcomes in Asia. Unlike biobanks that collect samples and freeze them for future analysis, HELIOS is designed for longitudinal follow-up, enabling researchers to track how genomic and molecular profiles evolve alongside changing health status.

The study’s multi-omics data are complemented by Singapore-specific lifestyle instruments, including food frequency questionnaires that capture local dietary patterns. This contextual richness allows researchers to move beyond correlation and toward mechanistic understanding of gene-environment interactions.

Real-World Translation: From Cohort to Clinic

The ultimate test of any population cohort is whether its findings change clinical practice. HELIOS data have already contributed to the identification of population-specific risk variants that inform the PPGx pilot’s diagnostic panels. Additionally, the multi-omic reference data are being used to develop AI models trained on local clinical data and practice guidelines, initially targeting cardiometabolic and ophthalmic diseases.

The Bigger Picture

HELIOS represents a philosophical shift in how Asian health research is conducted. Rather than treating diversity as noise to be controlled for, the study treats it as signal to be understood. For a region home to more than half the world’s population, this orientation is not merely scientifically interesting—it is clinically essential.